Toxicological and safety evaluations of W e issella cibaria strain CMU in animal toxicity and genotoxicity
- PMID: 35865276
- PMCID: PMC9247120
- DOI: 10.1007/s43188-021-00119-9
Toxicological and safety evaluations of W e issella cibaria strain CMU in animal toxicity and genotoxicity
Abstract
Weissella cibaria belongs to the Lactobacillaceae family and has been isolated from traditional fermented foods and saliva of children with good oral health. Previous investigations have shown that W. cibaria CMU (Chonnam Medical University) is expected to be safe based on results of in silico and in vitro analyses. However, there is a lack of studies assessing its safety in vivo. A toxicological safety evaluation of W. cibaria CMU was performed using an acute oral safety study in rats, a 14-day oral range finding study, a subsequent 13-week oral toxicity study in rats and a genetic toxicity battery (in vitro bacterial reverse mutation, in vitro chromosome aberration in Chinese Hamster Ovary cells and in vivo micronucleus study in mice). The results of the studies in rats showed that the acute lethal dose of W. cibaria CMU is > 5000 mg/kg body weight (bw)/day (1.8 × 109 CFU/kg bw/day) and the 14-day or 13-week no observed adverse effect level (NOAEL) is 5000 mg/kg bw/day (1.8 × 109 CFU/kg bw/day), the highest dose administered. W. cibaria CMU was non-mutagenic in the bacterial reverse mutation test and non-clastogenic or aneugenic in vitro and in vivo. In conclusion, the toxicological studies performed demonstrated W. cibaria CMU to be a safe strain to consume. This study is the first study examining the potential of a W. cibaria strain to cause genetic toxicity and subchronic toxicity in rats according to the Organization for Economic Cooperation and Development guidelines.
Keywords: Acute; Clastogenicity; Mutagenicity; NOAEL; Rat; Safety; Subchronic; Weissella cibaria.
© The Author(s) 2021.
Conflict of interest statement
Conflict of interestDolan LC and Arceneaux BG have a financial relationship with the sponsor (OraPharm, Inc.) of the manuscript. Park GY and Kang MS are employees of OraPharm Inc. The other authors do not have any conflicts of interest to declare.
Figures


Similar articles
-
Therapeutic Efficacy of Weissella cibaria CMU and CMS1 on Allergic Inflammation Exacerbated by Diesel Exhaust Particulate Matter in a Murine Asthma Model.Medicina (Kaunas). 2022 Sep 19;58(9):1310. doi: 10.3390/medicina58091310. Medicina (Kaunas). 2022. PMID: 36143987 Free PMC article.
-
Effects of Weissella cibaria CMU on Halitosis and Calculus, Plaque, and Gingivitis Indices in Beagles.J Vet Dent. 2019 Jun;36(2):135-142. doi: 10.1177/0898756419872562. Epub 2019 Sep 19. J Vet Dent. 2019. PMID: 31537147
-
Improvement of halitosis by probiotic bacterium Weissella cibaria CMU: A randomized controlled trial.Front Microbiol. 2023 Jan 17;14:1108762. doi: 10.3389/fmicb.2023.1108762. eCollection 2023. Front Microbiol. 2023. PMID: 36733919 Free PMC article.
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake.J Ophthalmol. 2016;2016:3690140. doi: 10.1155/2016/3690140. Epub 2016 Jan 13. J Ophthalmol. 2016. PMID: 26885380 Free PMC article. Review.
Cited by
-
Preventive effects of Weissella cibaria CMU on the progression of periodontitis in a rat model.J Oral Microbiol. 2025 Feb 23;17(1):2469895. doi: 10.1080/20002297.2025.2469895. eCollection 2025. J Oral Microbiol. 2025. PMID: 40007939 Free PMC article.
-
Therapeutic Efficacy of Weissella cibaria CMU and CMS1 on Allergic Inflammation Exacerbated by Diesel Exhaust Particulate Matter in a Murine Asthma Model.Medicina (Kaunas). 2022 Sep 19;58(9):1310. doi: 10.3390/medicina58091310. Medicina (Kaunas). 2022. PMID: 36143987 Free PMC article.
References
-
- Abriouel H, Lerma LL, Casado Muñoz Mdel C, Montoro BP, Kabisch J, Pichner R, Cho GS, Neve H, Fusco V, Franz CM, Gálvez A, Benomar N. The controversial nature of the Weissella genus: technological and functional aspects versus whole genome analysis-based pathogenic potential for their application in food and health. Front Microbiol. 2015;6:1197. doi: 10.3389/fmicb.2015.01197. - DOI - PMC - PubMed
-
- Nucleotide (2017) Weissella cibaria strain CMU, complete genome. National Center for Biotechnology Information, U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/nuccore/CP013936. Accessed 11 May 2021
LinkOut - more resources
Full Text Sources